SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IGT ((VSE:IGT) Blockbuster Anti-Cancer Test Results !!!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jean paul sauvT who wrote (27)11/28/1997 4:23:00 PM
From: Flea  Read Replies (1) of 94
 
IGT Pharma Inc -

3mo results

IGT Pharma Inc
IGT
Shares issued 7775915
1997-11-25 close $1.05
Wednesday Nov 26 1997
Mr Bruce Schmidt reports
As of September 30 1997, IGT reported assets of $1,550,991 of which cash and investments comprised
$1,276,241. There were no current or long term liabilities. Shares outstanding totalled 7,775,914
inclusive of 32,000 being issued during the quarter.
Revenue for the quarter was $56,781 comprised largely of interest income and grants. Research,
development and administrative expenses totalled $183,896. The loss for the period was $127,115 or
$42,372 per month.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News